Is Archit Organosys overvalued or undervalued?

As of 29 October 2025, the valuation grade for Archit Organosys has moved from attractive to fair. The company is currently fairly valued, with a PE ratio of 153.25, an EV to EBITDA ratio of 18.74, and a PEG ratio of 0.02. In comparison to its peers, Solar Industries has a PE of 100.25 and an EV to EBITDA of 61.69, while Godrej Industries, which is rated attractive, has a PE of 36.63 and an EV to EBITDA of 29.28.
Despite the recent stock performance lagging behind the Sensex, particularly in the 1-month and year-to-date periods, where it returned -1.31% and -2.47% respectively, the long-term perspective shows a significant 5-year return of 175.21% compared to the Sensex's 113.83%. This indicates that while Archit Organosys may be currently fairly valued, its historical performance suggests potential for future growth.